 |
ProductsAntisoma has a diverse portfolio of products in development. Our products target tumours by several different mechanisms and are intended for the treatment of a range of cancers 
Read more
|
Latest news
| 16/05/2008 | Antisoma to present at Rodman & Renshaw 5th Annual Global Healthcare Conference in Monte Carlo |   |
| 16/05/2008 | Antisoma to acquire Xanthus |   |
| 29/04/2008 | Antisoma Interim Management Statement | |
In focus
|
16/05/08 - Antisoma to acquire Xanthus | |
|
11/04/08 - ASA404 enters phase III trial in lung cancer | |
|
19/04/07 – Antisoma announces global agreement with Novartis for cancer drug AS1404 |
Share price
| 29.00 GBp |  1.50 |
| Date: | 16/05/2008 |
